Jackson Parish Hospital
Jackson Parish Hospital was paid $3.90M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
JONESBORO, LA 71251
Next to other Critical Access Hospital providers in Louisiana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,458 | $551K | |
| 2019 | 13,238 | $353K | |
| 2020 | 5,374 | $273K | |
| 2021 | 7,874 | $524K | |
| 2022 | 16,474 | $935K | |
| 2023 | 17,726 | $808K | |
| 2024incomplete | 8,851 | $461K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 8,362 | 7,316 | $1.36M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 4,868 | 4,159 | $1.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.7% | 1,552 | 1,274 | $380K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.0% | 1,860 | 1,597 | $195K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 256 | 218 | $111K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 1,502 | 1,133 | $103K |
| 80053 | Comprehensive metabolic panel | 2.1% | 11,853 | 9,178 | $83K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 1,317 | 1,017 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 12,338 | 9,662 | $68K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 2,382 | 1,831 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 806 | 594 | $50K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 51 | 41 | $41K |
88 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 438 | $38K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 762 | $33K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 226 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,766 | $20K |
| 87428 | <1% | 751 | $17K | |
| 87400 | <1% | 1,327 | $17K | |
| 80061 | Lipid panel | <1% | 1,467 | $16K |
| J3490 | Unclassified drugs | <1% | 443 | $14K |
| 87430 | <1% | 1,234 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 152 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 352 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 568 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 81 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 68 | $7K |
| 84484 | <1% | 1,034 | $7K | |
| 81025 | <1% | 922 | $6K | |
| 82728 | <1% | 586 | $6K | |
| 82553 | <1% | 1,072 | $6K | |
| 80050 | General health panel | <1% | 126 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 70 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 158 | $5K |
| 82550 | <1% | 1,330 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 561 | $4K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 120 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 279 | $4K |
| 83550 | <1% | 567 | $4K | |
| 0001A | <1% | 93 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 92 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 86 | $3K |
| 0002A | <1% | 79 | $3K | |
| 83880 | <1% | 252 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 231 | $3K |
| 83540 | <1% | 585 | $3K | |
| 0012A | <1% | 87 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 366 | $2K |
| 74018 | <1% | 28 | $2K | |
| 81003 | <1% | 1,401 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 31 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 36 | $2K |
| 86003 | <1% | 12 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 66 | $2K |
| 0011A | <1% | 70 | $1K | |
| 81001 | <1% | 608 | $1K | |
| 0013A | <1% | 33 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 77 | $917.13 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 71 | $746.61 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 21 | $641.35 |
| 74021 | <1% | 15 | $624.94 | |
| 83735 | <1% | 198 | $609.88 | |
| 82607 | <1% | 43 | $588.77 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 114 | $579.17 |
| 84439 | <1% | 76 | $569.03 | |
| 86308 | <1% | 90 | $537.21 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $535.66 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $519.96 |
| 83690 | <1% | 85 | $475.15 | |
| 86677 | <1% | 50 | $474.60 | |
| 82746 | <1% | 29 | $427.05 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $423.56 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $423.56 |
| 86140 | <1% | 103 | $398.99 | |
| 0031A | <1% | 19 | $366.54 | |
| 82248 | <1% | 76 | $302.72 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 534 | $232.86 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 575 | $218.55 |
| 82150 | <1% | 34 | $198.56 | |
| 87070 | <1% | 15 | $143.61 | |
| 85730 | <1% | 52 | $130.70 | |
| 85610 | <1% | 73 | $116.48 | |
| 90461 | <1% | 145 | $95.36 | |
| 87088 | <1% | 20 | $95.06 | |
| 85379 | <1% | 13 | $82.87 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,204 | $74.75 |
| 83615 | <1% | 14 | $54.36 | |
| 85018 | <1% | 124 | $52.14 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $45.45 |
| 87118 | <1% | 18 | $39.20 | |
| 91301 | <1% | 273 | $21.54 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,141 | $21.00 |
| 84134 | <1% | 24 | $7.59 | |
| 91300 | <1% | 231 | $0.08 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 2,101 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 288 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 15 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 52 | $0.00 |
| 87420 | 0% | 31 | $0.00 | |
| 80320 | 0% | 15 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 91 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Jackson Parish Hospital | Jonesboro, LA | $7.16M |
| Trustees of Tufts University | Waltham, MA | $2.96M |
| Another Chance Clinical Services LLC | Portland, OR | $2.86M |
| Trustees of Tufts University | Taunton, MA | $2.74M |
| Jackson Parish Hospital | Jonesboro, LA | $2.26M |
| Trustees of Tufts University | Worcester, MA | $2.21M |
| Jackson Parish Hospital | Chatham, LA | $1.66M |
| Trustees of Tufts University | Hathorne, MA | $1.39M |
| Trustees of Tufts College | Waltham, MA | $752K |
| Jackson Parish Hospital | Jonesboro, LA | $27K |
| Midwestern Dental of Woodhaven | Woodhaven, MI | $21K |
| Midwestern Dental of Sterling Heights | Sterling Heights, MI | $21K |
| Midwestern Dental of Warren | Warren, MI | $12K |
| Midwestern Dental of Dearborn | Dearborn, MI | $10K |
| Midwestern Dental of Lansing | Lansing, MI | $3K |
| Midwestern Dental of Farmington | Farmington, MI | $241.20 |
| Morgan Pharmacy INC | Jonesville, LA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.